White blood cells, nerve cells, bone cells, and *striated* muscle cells
Answer:
Thus, 50% of the population are are heterozygous carriers for this condition
Explanation:
Researchers have calculated that 22% of the population have Uner Tan Syndrome. This condition follows the recessive mode of inheritance.
22% have the condition = q² (genotypic frequency uu) = 22/100 = 0.22
using the formular p + q = 1, since q² = 0.22, q = √0.22 = 0.4690
Thus p = 1-q where is 0.4690 = 1-0.4690
p = 0.5310
Then p² = 0.5310² = 0.2820 = 28% (genotypic frequency of homozygous normal)
using the formula p² + 2pq + q² where 2pq is the genotypic frequency of the heterozygous carriers. Thus, we have
2 x 0.5310 x 0.4690 = 0.498 = 50%
Thus, 50% of the population are are heterozygous carriers for this condition
Yes, it is true that Mammalian target of rapamycin pathway mutations cause hemimegalencephaly and focal cortical dysplasia.
Focal malformations of cortical development, including focal cortical dysplasia (FCD) and hemimegalencephaly (HME), are important causes of intractable childhood epilepsy.
Using targeted and exome sequencing on DNA from resected brain samples and non-brain samples from 53 patients with FCD or HME, we identified pathogenic germline and mosaic mutations in multiple PI3K/AKT pathway genes in 9 patients, and a likely pathogenic variant in 1 additional patient.
Our data confirm the association of DEPDC5 with sporadic FCD but also implicate this gene for the first time in HME. Our findings suggest that modulation of the mammalian target of rapamycin pathway may hold promise for malformation-associated epilepsy.
Learn more about mutations here : brainly.com/question/17031191
#SPJ4
Fluids play an important role in maintaining homeostasis<span> within the body's systems.
</span>
Answer:
the scientific methothe formula and testing of a hypothesis is part of the scientific method
